Cargando…

2222. Impact of Empiric Aminoglycoside Usage on Outcomes in Bacterial Pneumonia

BACKGROUND: Although aminoglycosides are recommended as part of empiric combination therapy in selected patients with healthcare-associated pneumonia, their efficacy and safety remains unclear. The objectives of this study were to evaluate the impact of empiric aminoglycoside treatment on microbiolo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Albin, Owen, Patel, Twisha S, Henig, Oryan, Valley, Thomas, Pogue, Jason M, Petty, Lindsay A, Mills, John, Brancaccio, Adamo, Kaye, Keith S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811250/ http://dx.doi.org/10.1093/ofid/ofz360.1900

Ejemplares similares

1467. Clinical Significance of Microbiologic Treatment Failure Following Clinical Cure of Pneumonia
por: Albin, Owen, et al.
Publicado: (2018)

Overview of meropenem-vaborbactam and newer antimicrobial agents for the treatment of carbapenem-resistant Enterobacteriaceae
por: Petty, Lindsay A, et al.
Publicado: (2018)

223. Predicting Mortality Among Immunocompromised Patients Who Present With Bloodstream Infection
por: Henig, Oryan, et al.
Publicado: (2019)

Bacterial Pneumonia in Older Adults
por: Henig, Oryan, et al.
Publicado: (2017)

Rethinking the “Pan-Culture”: Clinical Impact of Respiratory Culturing in Patients With Low Pretest Probability of Ventilator-Associated Pneumonia
por: Albin, Owen R, et al.
Publicado: (2022)

Comparison of fidaxomicin to oral vancomycin for the treatment of Clostridioides difficile infection in hospitalized patients
por: Rao, A. Krishna, et al.
Publicado: (2022)

1567. Predicting Mortality Among Immunocompromised Patients Who Present with Infection
por: Henig, Oryan, et al.
Publicado: (2018)

Minocycline for the Treatment of Multidrug and Extensively Drug-Resistant A. baumannii: A Review
por: Lashinsky, Jennifer N., et al.
Publicado: (2017)

521. Comparative In Vitro Activity of Meropenem/Vaborbactam and Meropenem Against a Collection of Real-World Clinical Isolates of Pseudomonas aeruginosa
por: Patel, Twisha S, et al.
Publicado: (2019)

522. In Vitro Antimicrobial Activity of Ceftazidime/Avibactam Compared with Ceftolozane/Tazobactam Against Real-world Clinical Isolates of Pseudomonas aeruginosa at a Large Academic Tertiary Care Hospital
por: Patel, Twisha S, et al.
Publicado: (2019)

PReS-FINAL-2222: FMF presenting with the features of malignancy
por: Keskindemirci, G, et al.
Publicado: (2013)

318. Deferring Amputation in Diabetic Foot Osteomyelitis: Doing more Harm than Good?
por: Zhou, Shiwei, et al.
Publicado: (2020)

Deferring Amputation in Diabetic Foot Osteomyelitis: Doing More Harm Than Good?
por: Zhou, Shiwei, et al.
Publicado: (2021)

Effects of amino acid ionic liquids with different cations ([N(2)Py], [N(2222)], [P(2222)], and [C(2)mim]) on wheat seedlings
por: Chen, Zhonglin, et al.
Publicado: (2021)

Epidemiology of Diabetic Foot Infection in the Metro-Detroit Area With a Focus on Independent Predictors for Pathogens Resistant to Recommended Empiric Antimicrobial Therapy
por: Henig, Oryan, et al.
Publicado: (2018)

2152. Epidemiology and Clinical Outcomes of Contemporary, Third-Generation Left Ventricular Assist Device (LVAD) Infections
por: Hershberger, Todd E, et al.
Publicado: (2018)

The Impact of Multidrug-Resistant Organisms on Outcomes in Patients With Diabetic Foot Infections
por: Henig, Oryan, et al.
Publicado: (2020)

2406. “Real-world” Treatment of Multidrug-Resistant (MDR) or Extensively Drug-Resistant (XDR) P. aeruginosa Infections With Ceftolozane/Tazobactam (C/T) vs. a Polymyxin or Aminoglycoside (Poly/AG)-based Regimen: A Multicenter Comparative Effectiveness Study
por: Pogue, Jason M, et al.
Publicado: (2018)

2075. The Hypothetical Impact of Accelerate Pheno on Time to Appropriate Therapy (TTAT) and Time to Optimal Therapy (TTOT) in an Institution with an Established Antimicrobial Stewardship Program and Rapid Genotypic Organism/Resistance Marker Identification
por: Cooper, Christopher, et al.
Publicado: (2018)

1056. Evaluation of Clinical Outcomes Following Implementation of Real-Time Stewardship Team Interventions for Multi-Drug-Resistant Organisms
por: Xhemali, Xhilda, et al.
Publicado: (2019)

216. Step-down Therapy With Oral Fluoroquinolones vs. Oral β-Lactams for Hospitalized Adult Patients with Community-Acquired Pneumonia: A Multi-Hospital Cohort Study
por: Petty, Lindsay, et al.
Publicado: (2018)

869. Evaluation of Broad-Spectrum Antibiotic De-Escalation in Patients with Health-Care Associated Pneumonia (HCAP) and No Microbiological Diagnosis
por: Patel, Twisha S, et al.
Publicado: (2018)

The hypothetical impact of Accelerate Pheno™ system on time to effective therapy and time to definitive therapy in an institution with an established antimicrobial stewardship programme currently utilizing rapid genotypic organism/resistance marker identification
por: Henig, Oryan, et al.
Publicado: (2019)

Complete genome anatomy of the emerging potato pathogen Dickeya solani type strain IPO 2222(T)
por: Khayi, Slimane, et al.
Publicado: (2016)

2222. 3-Day Ceftriaxone vs. Longer Durations of Therapy For Inpatient Treatment of Uncomplicated UTI 
por: Elajouz, Balsam, et al.
Publicado: (2022)

1035. Implementation of an Antimicrobial Stewardship Program-Led, Multifactorial Pneumonia Diagnosis and Treatment Bundle
por: Cua, Jefferson L, et al.
Publicado: (2019)

2890. Antibiotic Overuse at Discharge in Hospitalized Patients with Bacteriuria or Treated for Pneumonia: A Multi-Hospital Cohort Study
por: Vaughn, Valerie M, et al.
Publicado: (2019)

1871. Identifying Time Periods of High and Low Vancomycin Use
por: Liu, Jiajun, et al.
Publicado: (2018)

1600. Susceptibility of β-Lactam-Resistant Pseudomonas aeruginosa to Other β-Lactams: Is There Truly a Lack of Cross-Resistance?
por: Patel, Twisha S, et al.
Publicado: (2019)

[2.2.2.2]Paracyclophanetetraenes (PCTs): cyclic structural analogues of poly( p‑phenylene vinylene)s (PPVs)
por: Pletzer, Matthias, et al.
Publicado: (2022)

PB2222: DOES LUNG LESION SEVERITY AFFECT THE OUTCOME IN PEDIATRIC PULMONARY MULTISYSTEM LANGERHANS CELL HISTIOCYTOSIS?
por: Sedky, Mohamed Sedky, et al.
Publicado: (2023)

Broad-spectrum suppression of bacterial pneumonia by aminoglycoside-propagated Acinetobacter baumannii
por: Hood-Pishchany, M. Indriati, et al.
Publicado: (2020)

CFTR Rescue in Intestinal Organoids with GLPG/ABBV-2737, ABBV/GLPG-2222 and ABBV/GLPG-2451 Triple Therapy
por: de Poel, Eyleen, et al.
Publicado: (2021)

PB2222: THE PROTECTIVE EFFECT OF THE SPLEEN IN SICKLE CELL PATIENTS. A COMPARATIVE STUDY BETWEEN PATIENTS WITH ASPLENIA AND HYPERSPLENISM.
por: Peretz, S., et al.
Publicado: (2022)

2000. Utilization of a ‘Never Event’ Framework to Classify Antimicrobial Appropriateness
por: Liu, Jiajun, et al.
Publicado: (2019)

1083. Risk Factors Associated with Treatment of Asymptomatic Bacteriuria in the Emergency Department: A Multi-Hospital Cohort Study
por: Petty, Lindsay A, et al.
Publicado: (2019)

2222. Impact of Sustained Virologic Response Achieved Through Newer Direct Acting Antivirals in Hepatitis C Infection on Diabetes Mellitus
por: Mada, Pradeep Kumar, et al.
Publicado: (2018)

Predictors of antimicrobial use in intensive care unit patients
por: Albin, Owen, et al.
Publicado: (2023)

European standard internal telephone number 2222 for in-hospital emergency calls: A national survey in all French military training hospitals
por: Py, Nicolas, et al.
Publicado: (2022)

Resistance of Dickeya solani strain IPO 2222 to lytic bacteriophage ΦD5 results in fitness tradeoffs for the bacterium during infection
por: Bartnik, Przemyslaw, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mgnb4h0mjb5iij6c12ft8g1hu5